Learn More
Medchemexpress LLC Halofuginone (hydrobromide) | 64924-67-0 | 495.59 | 25 MG

Supplier: Medchemexpress LLC 25MGHYN1584A
Halofuginone hydrobromide, a Febrifugine derivative, is a competitive prolyl-tRNA synthetase inhibitor. It specifically inhibits type-I collagen synthesis and helps reduce osteoarthritis by inhibiting TGF-β activity. It also acts as a potent pulmonary vasodilator by activating Kv channels and blocking various Ca2+ channels. This compound exhibits a range of beneficial effects.
- Competitively inhibits prolyl-tRNA synthetase
- Inhibits type-I collagen synthesis
- Attenuates osteoarthritis by inhibiting TGF-β activity
- Potent pulmonary vasodilator
- Activates Kv channels and blocks Ca2+ channels
- Exhibits anti-malaria effects
- Provides anti-inflammatory effects
- Shows anti-cancer activity
- Offers anti-fibrosis effects
- Decreases NRF2 protein levels in tumors
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.